Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1993-4-9
pubmed:abstractText
1. We have investigated the effects of diazoxide (a sulphonamide derivative) and cibenzoline (a class I antiarrhythmic drug) on ATP-sensitive K+ currents in guinea-pig ventricular cells, using whole-cell clamp techniques. 2. Diazoxide (50 microM) produced a marked shortening of action potential duration which was antagonized by 1 microM glibenclamide, an ATP-sensitive K+ channel blocker. 3. Diazoxide (50 microM) increased the quasi-steady state outward current elicited by a ramp voltage protocol (-20 mV s-1) at potentials positive to about -70 mV. This effect was completely prevented in the presence of glibenclamide (1 microM), thereby suggesting that diazoxide opens ATP-sensitive K+ channels. 4. Cibenzoline (5 microM) depressed the diazoxide-induced increases in the outward current and the pretreatment with this agent prevented the development of the diazoxide-induced outward current. 5. Cibenzoline (10 microM) reversed the 2,4-dinitrophenol (50 microM)-induced shortening of the action potential duration partially but significantly. 6. These results suggest that diazoxide activates ATP-sensitive K+ channels of guinea-pig ventricular cells and that cibenzoline, at therapeutic concentrations, inhibits this channel.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-1908354, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-1908730, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-1909501, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2105170, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2119912, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2240258, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2410609, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2412077, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2412127, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2431383, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2442716, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2447283, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2452991, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2453509, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2456513, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2456760, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2460821, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2480177, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2504288, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2526215, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2674891, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2676059, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2752550, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-2899265, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-3085830, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-3545736, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-3598914, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-3708204, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-4683074, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6089098, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6090930, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6095103, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6131003, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6200720, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6270629, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6310409, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6476980, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6861865, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6889093, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-6998294, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-7046755, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-7066601, http://linkedlifedata.com/resource/pubmed/commentcorrection/8448602-7328906
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
549-56
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Cibenzoline inhibits diazoxide- and 2,4-dinitrophenol-activated ATP-sensitive K+ channels in guinea-pig ventricular cells.
pubmed:affiliation
Department of Physiology, Oita Medical University, Japan.
pubmed:publicationType
Journal Article, In Vitro